HIGHFDA DEVICE

Philips Allura Xper FD20 Biplane Recall Affects 268 Units Worldwide (2025)

Philips Medical Systems Nederland B.V. recalled 268 Allura Xper FD20 Biplane imaging systems worldwide, including 102 in the United States. The recall cites deterioration of internal components that could disable motorized movements. Hospitals should stop using the devices immediately and follow the manufacturer’s recall instructions.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
September 3, 2025
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
September 3, 2025
Hazard Level
HIGH
Brand
Philips Medical Systems
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Philips Medical Systems
Product type
Interventional Fluoroscopy System (Biplane)
Model numbers
722013, 722008
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 3, 2025

  2. Reported by FDA DEVICE

    October 1, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Systems may not perform as intended due to the deterioration of certain internal components (the CMOS battery, hard disk drive, and/or power supply unit). If this deterioration occurs, motorized movements of the system will become unavailable. Manual movements of the stand (longitudinal, transversal and rotational for ceiling mounted systems and rotational for floor mounted systems) and table longitudinal movements remain available. Imaging (X-ray) functionality remains available.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: Letter

About This Product

The Allura Xper FD20 is a biplane interventional X-ray imaging system used in catheter-based procedures. Patients typically undergo imaging-guided interventions in hospital settings. The recall concerns internal components that may degrade over time.

Why This Is Dangerous

If the CMOS battery, HDD, or PSU deteriorate, motorized movements could fail during use. This could disrupt procedures, though manual movements and imaging remain available.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Hospitals may experience procedure delays or mechanical interruptions. The issue requires immediate corrective action to ensure patient safety and procedural continuity.

Practical Guidance

How to identify if yours is affected

  1. Verify device is Allura Xper FD20 Biplane with model numbers 722013 or 722008
  2. Check recall notice and manufacturer correspondence for confirmation
  3. Review service history and component status (battery, HDD, PSU) on the device

Where to find product info

Serial numbers and date codes are typically on the device label and in service manuals; follow Philips recall communications for exact identifiers.

What timeline to expect

Immediate action required. Replacement or repair arrangements will be scheduled by Philips; timelines vary by facility and kit availability.

If the manufacturer is unresponsive

  • Escalate to hospital risk management and procurement
  • Contact Philips support through official channels as provided in recall letter
  • File a report with regulatory bodies if the company delays remediation

How to prevent similar issues

  • Verify device recalls during procurement of interventional imaging systems
  • Ask for recall-clearance documentation before accepting equipment
  • Maintain updated service agreements and firmware that support traceability

Documentation advice

Keep copy of recall notice, letters, service tickets, and correspondence with Philips. Document all steps taken and any procedural changes.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: 722013, 722008. Sold worldwide, including 102 units in the United States and 166 outside the U.S. Recall date: 2025-09-03. Distributor/manufacturer: Philips Medical Systems Nederland B.V. (Philips). Price: Not disclosed.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 268 total units recalled (102 US, 166 outside US)
  • Model numbers 722013 and 722008
  • Cause: deterioration of CMOS battery, HDD, PSU
  • Motorized movements may fail; manual movements still available
  • Imaging function remains available
  • Recall date 2025-09-03; report date 2025-10-01

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
722013
722008
Affected States
ALL
Report Date
October 1, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more